243 related articles for article (PubMed ID: 20495642)
1. Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study.
Bower M; Metzger T; Robbins K; Tomalty D; Válek V; Boudný J; Andrasina T; Tatum C; Martin RC
HPB (Oxford); 2010 Feb; 12(1):31-6. PubMed ID: 20495642
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
Bhutiani N; Akinwande O; Martin RC
World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
[TBL] [Abstract][Full Text] [Related]
3. Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study.
Martin RC; Joshi J; Robbins K; Tomalty D; Bosnjakovik P; Derner M; Padr R; Rocek M; Scupchenko A; Tatum C
Ann Surg Oncol; 2011 Jan; 18(1):192-8. PubMed ID: 20740319
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.
Martin RC; Robbins K; Tomalty D; O'Hara R; Bosnjakovic P; Padr R; Rocek M; Slauf F; Scupchenko A; Tatum C
World J Surg Oncol; 2009 Nov; 7():80. PubMed ID: 19886993
[TBL] [Abstract][Full Text] [Related]
5. PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
Jones RP; Malik HZ; Fenwick SW; Terlizzo M; O'Grady E; Stremitzer S; Gruenberger T; Rees M; Plant G; Figueras J; Albiol M; Adam R; Awad S; Poston GJ
Eur J Surg Oncol; 2016 Dec; 42(12):1866-1872. PubMed ID: 27561844
[TBL] [Abstract][Full Text] [Related]
6. Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.
Pernot S; Artru P; Mithieux F; Marsot J; Watkin E; Pellerin O; Lledo G; Chalabreysse P; Desramé J; Taieb J
Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):e73-7. PubMed ID: 26141343
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy.
Aliberti C; Carandina R; Sarti D; Mulazzani L; Catalano V; Felicioli A; Coschiera P; Fiorentini G
Anticancer Res; 2016 Jul; 36(7):3515-21. PubMed ID: 27354617
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver.
van Riel JM; van Groeningen CJ; de Greve J; Gruia G; Pinedo HM; Giaccone G
Ann Oncol; 2004 Jan; 15(1):59-63. PubMed ID: 14679121
[TBL] [Abstract][Full Text] [Related]
9. Segmental and lobar administration of drug-eluting beads delivering irinotecan leads to tumour destruction: a case-control series.
Jones RP; Dunne D; Sutton P; Malik HZ; Fenwick SW; Terlizzo M; O'Grady E; Koelblinger C; Stättner S; Stremitzer S; Gruenberger T; Poston GJ
HPB (Oxford); 2013 Jan; 15(1):71-7. PubMed ID: 23216781
[TBL] [Abstract][Full Text] [Related]
10. Early Experience with 70-150 μm Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
Akinwande O; Scoggins C; Martin RC
Anticancer Res; 2016 Jul; 36(7):3413-8. PubMed ID: 27354601
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population.
Huppert P; Wenzel T; Wietholtz H
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):154-64. PubMed ID: 23670568
[TBL] [Abstract][Full Text] [Related]
12. Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry.
Martin RC; Howard J; Tomalty D; Robbins K; Padr R; Bosnjakovic PM; Tatum C
Cardiovasc Intervent Radiol; 2010 Oct; 33(5):960-6. PubMed ID: 20661569
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.
Richardson AJ; Laurence JM; Lam VW
J Vasc Interv Radiol; 2013 Aug; 24(8):1209-17. PubMed ID: 23885916
[TBL] [Abstract][Full Text] [Related]
14. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.
Martin RC; Edwards MJ; McMasters KM
Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489
[TBL] [Abstract][Full Text] [Related]
15. Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.
Iezzi R; Marsico VA; Guerra A; Cerchiaro E; Cassano A; Basso M; Devicienti E; Rodolfino E; Barone C; Bonomo L
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1523-31. PubMed ID: 25799948
[TBL] [Abstract][Full Text] [Related]
16. Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin.
Eyol E; Boleij A; Taylor RR; Lewis AL; Berger MR
Clin Exp Metastasis; 2008; 25(3):273-82. PubMed ID: 18259882
[TBL] [Abstract][Full Text] [Related]
17. Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) for colorectal liver metastases does not predict tumour destruction or long-term outcome.
Jones RP; Stättner S; Dunne DF; O'Grady E; Smethurst A; Terlizzo M; Malik HZ; Fenwick SW; Poston GJ
Eur J Surg Oncol; 2013 Oct; 39(10):1122-8. PubMed ID: 23928482
[TBL] [Abstract][Full Text] [Related]
18. Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: results of a phase I clinical study.
Fiorentini G; Lucchi SR; Giovanis P; Cantore M; Guadagni S; Papiani G
Tumori; 2001; 87(6):388-90. PubMed ID: 11989591
[TBL] [Abstract][Full Text] [Related]
19. Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial.
Martin RC; Scoggins CR; Tomalty D; Schreeder M; Metzger T; Tatum C; Sharma V
J Gastrointest Surg; 2012 Aug; 16(8):1531-8. PubMed ID: 22528576
[TBL] [Abstract][Full Text] [Related]
20. Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.
Aliberti C; Fiorentini G; Muzzio PC; Pomerri F; Tilli M; Dallara S; Benea G
Anticancer Res; 2011 Dec; 31(12):4581-7. PubMed ID: 22199334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
